![Lawrence Alleva](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lawrence Alleva
Presidente presso
ADAPTIMMUNE THERAPEUTICS PLC
Patrimonio netto: 994 830 $ in data 31/07/2026
Profilo
Lawrence M.
Alleva is Chairman at Adaptimmune Therapeutics Plc since 2025.
Mr. Alleva is Director at Bright Horizons Family Solutions LLC.
Mr. Alleva is Independent Director at Bright Horizons Family Solutions, Inc. since 2012.
Former roles include Vice Chairman at Ithaca College; Chairman at Galera Therapeutics, Inc. (US) from 2025 to 2026; Director at Tesaro, Inc. from 2012 to 2019; Director at GlobalLogic, Inc. from 2011 to 2014; Independent Director at Mersana Therapeutics, Inc. from 2017 to 2026; Non-Executive Director at Adaptimmune Ltd.; Independent Director at Mirna Therapeutics, Inc. from 2015 to 2017; Partner at PricewaterhouseCoopers LLP from 1971 to 2010.
Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at Ithaca College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 03/06/2026 | 13.336 ( 0,03% ) | 994 065 $ | 31/07/2026 | |
| 11/04/2025 | 143.364 ( 0,01% ) | 764 $ | 31/07/2026 | |
| 06/01/2026 | 0 ( -.--% ) | - $ | 31/12/2025 |
Posizioni attive di Lawrence Alleva
| Società | Posizione | Inizio |
|---|---|---|
| BRIGHT HORIZONS FAMILY SOLUTIONS INC. | Direttore/Membro del Consiglio | 01/09/2012 |
| ADAPTIMMUNE THERAPEUTICS PLC | Presidente | 14/11/2025 |
Bright Horizons Family Solutions LLC
 Bright Horizons Family Solutions LLC Other Consumer ServicesConsumer Services Provides early education and preschools, employer-sponsored child care, educational advisory, work and life solutions | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Lawrence Alleva
| Società | Posizione | Fine |
|---|---|---|
| GALERA T COM USD0. | Presidente | 03/08/2026 |
| MERSANA THERAPEUTICS | Direttore/Membro del Consiglio | 06/01/2026 |
| TESARO INC | Direttore/Membro del Consiglio | 01/01/2019 |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Direttore/Membro del Consiglio | 01/09/2017 |
GlobalLogic, Inc.
 GlobalLogic, Inc. Information Technology ServicesTechnology Services Provides digital engineering, AI and data services | Direttore/Membro del Consiglio | 01/06/2014 |
Formazione di Lawrence Alleva
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
75
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Bright Horizons Family Solutions LLC
Bright Horizons Family Solutions LLC Other Consumer ServicesConsumer Services Provides early education and preschools, employer-sponsored child care, educational advisory, work and life solutions | Consumer Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Bright Horizons Family Solutions, Inc.
 Bright Horizons Family Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides child care and educational services | Commercial Services |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ithaca College
 Ithaca College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlobalLogic, Inc.
GlobalLogic, Inc. Information Technology ServicesTechnology Services Provides digital engineering, AI and data services | Technology Services |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Commercial Services |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious diseases | Health Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
